Skip to content
OpenCapital
Get started

Agilent Technologies A Life Sciences and Diagnostics Markets — Net revenue

Other segment segments

Agilent CrossLab
$759M+6.5%
Applied Markets
$344M+14.3%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOLife Science — Net Sales
$228.5M0.0%
Materion logo
MTRNLife sciences — Net Sales
-$1.53M-113%
Donaldson Company logo
DCILife Sciences Segment — Net Sales
$83.5M+12.5%
GLW
GLWLife Science Products — Net Sales
$228M0.0%
Revvity logo
RVTYLife Sciences — Segment revenue
$361.85M+6.3%
ExlService Holdings logo
EXLSHealthcare and Life Sciences — Revenues, net
$152.12M+20.9%

Other financials

Income statement

See full
Revenue$1.8B+10.0%
Gross profit$990.0M+14.3%
Operating income$399.0M+33.0%
Net income$339.0M+57.7%
EPS (diluted)$1.20+60.0%

Balance sheet

See full
Cash & equivalents$1.8B+21.5%
Total debt$3.5B-3.9%
Total equity$7.1B+16.1%
Total assets$13.1B+7.5%

Cash flow

See full
Operating cash flow$277.0M+25.3%
CapEx$76.0M-33.3%
Free cash flow$201.0M+87.9%

Valuation

See full
Market cap$38.41B+15.0%
Enterprise value$40.15B+12.7%
P/E27.2×-1.5×
P/S5.3×+0.3×

Profitability

See full
Gross margin52.7%-0.6pp
Operating margin21.5%+0.1pp
Net margin19.6%+2.0pp
FCF margin15%-2.9pp

Returns & leverage

See full
Return on equity21.3%+2.4pp
Debt / equity0.5×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's life sciences and diagnostics markets — net revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilent Technologies's life sciences and diagnostics markets — net revenue?
Agilent Technologies (A) reported life sciences and diagnostics markets — net revenue of $732M in Q1 2026.
How has Agilent Technologies's life sciences and diagnostics markets — net revenue changed year-over-year?
Agilent Technologies's life sciences and diagnostics markets — net revenue increased by 11.9% year-over-year, from $654M to $732M.
What is the long-term trend for Agilent Technologies's life sciences and diagnostics markets — net revenue?
Over 2 years (2023 to 2025), Agilent Technologies's life sciences and diagnostics markets — net revenue has grown at a -1.0% compound annual growth rate (CAGR), from $2.78B to $2.73B.
What does life sciences and diagnostics markets — net revenue mean?
This represents the total gross sales generated by the Life Sciences and Diagnostics business segment after deducting returns, allowances, and discounts. It serves as the primary indicator of market demand for the company's specialized analytical instruments, software, and diagnostic solutions.